{"id":"8215b0fc-1279-5f0b-a442-26bf1b4a37ce","stable_key":"548ab9d6-3a9b-5bed-879c-17d03813b636:b2-met-etfdh-severe-rescue-boundary","predicate":"limits-riboflavin-rescue","statement":"ETFDH variants associated with nonresponsive or partially responsive MADD showed severe misfolding in HEK-293 cells even in riboflavin-supplemented medium.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"85f7bb72-d976-5b8f-9486-fcb938a43453","mechanism_event_label":"Some inherited ETF-QO defects remained severe despite greater B2 supply.","subject":{"id":"c58bbfd3-2d2a-56a8-be86-ce22d1790cb2","slug":"etfdh-2012-variant-panel","display_name":"Human ETF-QO variants studied by Cornelius 2012","entity_type_key":"protein_set"},"object":{"id":"9f78394a-ddd1-5874-a9f7-e848262b5761","slug":"etfdh","display_name":"Human electron transfer flavoprotein dehydrogenase / ETFDH","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"85f7bb72-d976-5b8f-9486-fcb938a43453","stable_key":"548ab9d6-3a9b-5bed-879c-17d03813b636:b2-met-etfdh-severe-rescue-boundary-event","event_type":"biochemical_relationship","label":"Some inherited ETF-QO defects remained severe despite greater B2 supply.","description":"ETFDH variants associated with nonresponsive or partially responsive MADD showed severe misfolding in HEK-293 cells even in riboflavin-supplemented medium.","status":"provisional","compartment":{"slug":"mitochondria","display_name":"Mitochondria"},"participants":[{"entity":{"id":"86eb1eee-a8d1-539c-8c17-0911f69b6f1b","slug":"riboflavin","display_name":"Riboflavin (vitamin B2)","entity_type_key":"small_molecule"},"role":"culture exposure","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"e2cd7179-f218-54e8-9ce9-7a836ae35fac","slug":"fad","display_name":"FAD","entity_type_key":"small_molecule"},"role":"derived protein cofactor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"c58bbfd3-2d2a-56a8-be86-ce22d1790cb2","slug":"etfdh-2012-variant-panel","display_name":"Human ETF-QO variants studied by Cornelius 2012","entity_type_key":"protein_set"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"9f78394a-ddd1-5874-a9f7-e848262b5761","slug":"etfdh","display_name":"Human electron transfer flavoprotein dehydrogenase / ETFDH","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_spans","value_text":"[{\"source_bundle\": \"artifacts/riboflavin_metabolism_sources.json\", \"source_key\": \"PMID22611163\", \"locator\": \"metadata.abstractText\", \"paragraph_index\": 0, \"char_start\": 0, \"char_end\": 1899, \"evidence_access\": \"primary-abstract\"}]","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human HEK-293 cells expressing patient-associated ETF-QO variants under varied riboflavin and temperature.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Clinical-response-defined ETFDH variants; supplemented culture riboflavin.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Primary abstract-level claim; variants are grouped by this study, not a universal response classifier.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Riboflavin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"riboflavin","display_name":"Riboflavin (vitamin B2)","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Some inherited ETF-QO defects remained severe despite greater B2 supply.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[cornelius-2012-etfdh-rescue] Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency (2012). https://pubmed.ncbi.nlm.nih.gov/22611163/ DOI: 10.1093/hmg/dds175","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"HEK-293 expression system","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"6cf05619-cdf4-59cd-9721-31403aa37928","evidence_kind":"source_excerpt","locator":"Lines 808-819","start_line":808,"end_line":819,"excerpt":"### b2-met-etfdh-severe-rescue-boundary\nETFDH variants associated with nonresponsive or partially responsive MADD showed severe misfolding in HEK-293 cells even in riboflavin-supplemented medium.\nCondition category: machinery_impairment\nnutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Some inherited ETF-QO defects remained severe despite greater B2 supply.\norganism: Homo sapiens\ntissue_or_cell_type: HEK-293 expression system\nexperimental_model: Human HEK-293 cells expressing patient-associated ETF-QO variants under varied riboflavin and temperature.\nlimitations: Primary abstract-level claim; variants are grouped by this study, not a universal response classifier.\nexposure: Clinical-response-defined ETFDH variants; supplemented culture riboflavin.\nevidence_spans: [{\"source_bundle\": \"artifacts/riboflavin_metabolism_sources.json\", \"source_key\": \"PMID22611163\", \"locator\": \"metadata.abstractText\", \"paragraph_index\": 0, \"char_start\": 0, \"char_end\": 1899, \"evidence_access\": \"primary-abstract\"}]\n[cornelius-2012-etfdh-rescue] Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency (2012). https://pubmed.ncbi.nlm.nih.gov/22611163/ DOI: 10.1093/hmg/dds175","model_system":"Human HEK-293 cells expressing patient-associated ETF-QO variants under varied riboflavin and temperature.","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [cornelius-2012-etfdh-rescue] Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency (2012). https://pubmed.ncbi.nlm.nih.gov/22611163/ DOI: 10.1093/hmg/dds175","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4f7c9578-82bf-5e2d-b5c4-72a79fb4f6af","stable_key":"import-548ab9d6-3a9b-5bed-879c-17d03813b636","title":"Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"680cb6bc8249877f2410f551807f10d390fdd719014137d7414ba3420e29228d","revision_id":"7a61e299-908d-5372-860b-99ed190f9d7a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}